American Academy of Otolaryngology -- Head and Neck Surgery
Hay fever may be best treated with self-adjusted dosing
Published in Immunotherapy Weekly, October 15th, 2008
During the study by Thai researchers, hay fever, known clinically as allergic rhinitis, was observed in 69 patients, who were then treated over the course of 28 days with the intranasal corticosteroid triamcinolone acetonide. Patients with mild symptoms were instructed to use the treatment only after symptoms occurred once a day; patients with more severe symptoms were told to continue morning...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2008-10-15)
More Articles from Immunotherapy Weekly
- American Academy of Neurology
Majority of children vaccinated against hepatitis B not at increased risk of MS - Children's Memorial Hospital
Society's lack of food allergies impacts those afflicted with food allergies - University of Rochester Medical Center
New study proves that pain is not a symptom of arthritis, pain causes arthritis - Autoimmune Disease
Data from University of Saarland provide new insights into autoimmune disease - Autoimmune Disease
New autoimmune disease study findings have been reported by scientists at University Hospital - Behcet Disease
New Behcet disease study findings have been published by scientists at Yokohama City University, Medical Department - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
